Invention Grant
- Patent Title: Implant compositions for the unidirectional delivery of therapeutic compounds to the brain
-
Application No.: US15928057Application Date: 2018-03-21
-
Publication No.: US10434063B2Publication Date: 2019-10-08
- Inventor: Michael J. McGinity , Feng Zhang , John R. Floyd , James W. McGinity
- Applicant: Board of Regents, the University of Texas System
- Applicant Address: US TX Austin
- Assignee: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
- Current Assignee: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
- Current Assignee Address: US TX Austin
- Agency: Parker Highlander PLLC
- Main IPC: A61K47/36
- IPC: A61K47/36 ; A61K47/14 ; A61K31/337 ; A61K31/538 ; A61K31/573 ; A61K33/24 ; A61K9/00 ; A61K31/282 ; A61K31/495 ; A61K39/395 ; A61K31/436 ; A61K31/4745 ; A61K31/40 ; A61K31/704 ; A61K31/519 ; A61K31/155 ; A61K31/198 ; A61K31/661 ; A61K47/10 ; A61K47/12 ; A61L27/54
Abstract:
The present invention provides, in some aspects, bilayered and trilayered pharmaceutical implant compositions for the unidirectional delivery of anti-cancer compounds to the brain over a period of time (e.g., several weeks, 1, 2, 3, 4, 5, 6, 7 days, or 1, 2, 3, weeks, or any range derivable therein) following the removal of glioblastoma multiforme or other malignant tumors in the brain.
Public/Granted literature
- US20180311157A1 IMPLANT COMPOSITIONS FOR THE UNIDIRECTIONAL DELIVERY OF THERAPEUTIC COMPOUNDS TO THE BRAIN Public/Granted day:2018-11-01
Information query
